Have a feature idea you'd love to see implemented?
Let us know!
ASTH Astrana Health Inc.
Price (delayed)
$42.11
Market cap
$2.37B
P/E Ratio
32.15
Dividend/share
N/A
EPS
$1.31
Enterprise value
$2.5B
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based
Highlights
The revenue is up by 30% year-on-year and by 8% since the previous quarter
ASTH's gross profit is up by 20% year-on-year
Astrana Health's net income has increased by 40% YoY but it has decreased by 9% QoQ
The EPS has grown by 39% year-on-year but it has declined by 9% since the previous quarter
The debt has surged by 102% year-on-year
Astrana Health's gross margin has decreased by 7% from the previous quarter and by 7% YoY
Key stats
What are the main financial stats of ASTH
Market
Valuations
Earnings
Shares outstanding
56.25M
Market cap
$2.37B
Enterprise value
$2.5B
Price to earnings (P/E)
32.15
Price to book (P/B)
3.36
Price to sales (P/S)
1.37
EV/EBIT
20.99
EV/EBITDA
16.13
EV/Sales
1.45
Revenue
$1.72B
EBIT
$118.93M
EBITDA
$154.76M
Free cash flow
$69.89M
Per share
Balance sheet
Liquidity
EPS
$1.31
Free cash flow per share
$1.24
Book value per share
$12.53
Revenue per share
$30.64
TBVPS
$13.64
Total assets
$1.29B
Total liabilities
$778.27M
Debt
$475.82M
Equity
$704.62M
Working capital
$284.06M
Debt to equity
0.68
Current ratio
1.91
Quick ratio
1.79
Net debt/EBITDA
0.83
Margins
Efficiency
Dividend
EBITDA margin
9%
Gross margin
15.1%
Net margin
3.6%
Operating margin
4.9%
Return on assets
5.3%
Return on equity
9.4%
Return on invested capital
24%
Return on capital employed
12.2%
Return on sales
6.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASTH stock price
How has the Astrana Health stock price performed over time
Intraday
2.61%
1 week
0.5%
1 month
-29.95%
1 year
28.42%
YTD
9.95%
QTD
-27.32%
Financial performance
How have Astrana Health's revenue and profit performed over time
Revenue
$1.72B
Gross profit
$259.89M
Operating income
$84.76M
Net income
$62.46M
Gross margin
15.1%
Net margin
3.6%
Astrana Health's net income has increased by 40% YoY but it has decreased by 9% QoQ
The company's operating margin fell by 36% YoY and by 18% QoQ
The revenue is up by 30% year-on-year and by 8% since the previous quarter
ASTH's gross profit is up by 20% year-on-year
Growth
What is Astrana Health's growth rate over time
Valuation
What is Astrana Health stock price valuation
P/E
32.15
P/B
3.36
P/S
1.37
EV/EBIT
20.99
EV/EBITDA
16.13
EV/Sales
1.45
The EPS has grown by 39% year-on-year but it has declined by 9% since the previous quarter
The price to earnings (P/E) is 6% lower than the last 4 quarters average of 33.4 and 4.5% lower than the 5-year quarterly average of 32.8
ASTH's price to book (P/B) is 30% lower than its 5-year quarterly average of 4.7 and 14% lower than its last 4 quarters average of 3.8
Astrana Health's equity has increased by 19% YoY and by 3.8% from the previous quarter
ASTH's P/S is 39% below its 5-year quarterly average of 2.2 and 16% below its last 4 quarters average of 1.6
The revenue is up by 30% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Astrana Health business performance
Astrana Health's return on assets has increased by 20% YoY but it has decreased by 13% QoQ
Astrana Health's return on equity has increased by 19% YoY but it has decreased by 13% QoQ
The return on sales has declined by 10% since the previous quarter and by 8% year-on-year
The company's return on invested capital fell by 8% QoQ but it rose by 5% YoY
Dividends
What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASTH.
Financial health
How did Astrana Health financials performed over time
The total assets is 65% more than the total liabilities
The company's total liabilities has surged by 70% YoY
Astrana Health's quick ratio has decreased by 21% YoY but it has increased by 4.7% from the previous quarter
The debt is 32% smaller than the equity
The debt has surged by 102% year-on-year
The company's debt to equity has surged by 70% YoY but it fell by 2.9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.